基于酸化概况的肝细胞癌患者内部和患者间的多样性 - - 一个单一机构的试点研究
Kan Toriguchi1, Etsuro Hatano2, Makoto Sudo3
1Department of Gastroenterological Surgery, Hyogo Medical University, 1-1 Mukogawacho Nishinomiya city, Hyogo, Japan; Department of Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, Hyogo, Japan.
肝细胞癌 (HCC) 瘤表现出不同的受体氨酸激酶 (RTK) 激活. 了解这些多样化的酸化特征是开发药物耐药HCC有效组合疗法的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 在肝细胞癌 (HCC) 中,向药物的疗效受到瘤耐药性的限制.
- 组合疗法对于克服HCC药物耐药性至关重要.
- 了解激酶信号对于开发新的HCC治疗方法至关重要.
研究的目的:
- 在HCC.中分析与癌症相关的氨酸激酶的酸化概况.
- 为了确定HCC的潜在治疗点.
- 探索扩大HCC的组合治疗选择.
主要方法:
- 来自10名患者的全血,HCC组织和邻近的肝脏组织的分析.
- 利用人类RTK酸化抗体阵列来评估受体氨酸激酶 (RTK) 激活.
- 患者被选为乙型肝炎/C型肝炎RNA和严重饮酒史.
主要成果:
- 在62个基RTK中,有26个在瘤组织中被激活.
- 在90%的HCC病例中,ACK1,Dtk,Fyn和Lyn被激活.
- 在血清和组织样本中观察到RTK酸化概况的显著患者间和患者内多样性.
结论:
- 与癌症相关的RTK激活存在显著的患者特异性差异.
- 这些数据支持针对HCC的个性化组合治疗策略.
- 进一步的研究可以预测和优先考虑临床试验的最佳目标组合.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
相关概念视频
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
